Epithelioid Sarcoma

A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

Compassionate Use of Ubamatamab

Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients

Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group

Evaluate the Safety and Clinical Activity of HH2853

An Observational Study on Epithelioid Sarcoma

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Epithelioid Sarcoma Natural History Study

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Trial of Dasatinib in Advanced Sarcomas